With 10 years of research, the Aurora team has developed expertise in the use of plasma to reduce biological and chemical contamination. In the case of sterilization, we have developed innovative solutions to bring forward a new standard of performance in patient protection.
The commitment of the innovators involved in Aurora was rewarded on February 14, 2022. The French Minister of Higher Education, Research and Innovation, Mrs. Frédérique Vidal, announced to Aurora Cold Plasma Sterilisation that it is part of 15 projects selected to fight against future epidemics and CBRN threats*.
This recognition highlights the innovation of a French team from the University of Reims-Champagne-Ardenne. This award comes with significant funding that will accelerate Aurora Cold Plasma Sterilisation’s investments.
In addition to its work on hospital sterilization, Aurora Cold Plasma Sterilisation can thus put its cold plasma technology at the service of civil and military CBRN* decontamination.
A prototype is being designed to decontaminate equipment after an attack or accident involving bacteriological and chemical agents. The project will also work on a plasma spray to decontaminate vehicles, public spaces, or even hair and skin.
The dual application of this project will provide the pharmaceutical industry with a new way of sterilising single-use medical devices, in a cleaner and more economical may. Indeed, plasma can replace ethylene oxide, a highly controversial sterilant because of its carcinogenic, explosive and corrosive properties.
*Chemical Bacteriological Radiological Nuclear